Low-Dose Streptozocin-Induced Autoimmune Diabetes in Islet Transplantation Model

No abstract is available for this paper.

• Publication year

  1991

• Venue

  Diabetes

• Publication date

  1991-09-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.2337/diab.40.9.1157PMID 1834505
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Islet implantation into diabetic mice with pancreatic insulitis.

  2009cited by this paper
• Susceptibility to db gene and streptozotocin-induced diabetes in C57BL mice: control by gender-associated, MHC-unlinked traits

  2004cited by this paper
• Modulation of low-dose streptozotocin-induced diabetes in mice by administration of antibodies to I-A, I-E and I-J determinants

  1989cited by this paper
• Low-Dose Streptozocin-Induced Diabetes in Mice: Electron Microscopy Reveals Single-Cell Insulitis Before Diabetes Onset

  1988cited by this paper
• Specific Immunity to Streptozocin: Cellular Requirements for Induction of Lymphoproliferation

  1988cited by this paper
• EFFECT OF LOW‐TEMPERATURE CULTURE AND SITE OF TRANSPLANTATION ON HAMSTER ISLET XENOGRAFT SURVIVAL (HAMSTER TO MOUSE)

  1987cited by this paper
• L3T4 and Lyt-2 T cells are both involved in the generation of low-dose streptozotocin-induced diabetes in mice.

  1987cited by this paper
• ANALYSIS OF DIFFERENTIAL SURVIVAL OF SYNGENEIC ISLETS TRANSPLANTED INTO HYPERGLYCEMIC C57BL/6J VERSUS C57BL/KsJ MICE

  1987cited by this paper
• Mouse models of insulin dependent diabetes: low-dose streptozocin-induced diabetes and nonobese diabetic (NOD) mice.

  1987cited by this paper
• Treatment With Anti-T-Lymphocyte Antibodies Prevents Induction of Insulitis in Mice Given Multiple Doses of Streptozocin

  1987cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• Administration of silica or monoclonal antibody to Thy-1 prevents low-dose streptozotocin-induced diabetes in mice.

  1986cited by this paper
• Suppression of low-dose streptozotocin-induced diabetes by immunomodulatory lectins.

  1986cited by this paper
• Type I diabetes mellitus. A chronic autoimmune disease.

  1986cited by this paper
• Progressive Damage of Cultured Pancreatic Islets After Single Early Exposure to Streptozocin

  1986cited by this paper
• Definition of Streptozocin Toxicity for Primary Lymphoidal Tissues

  1986cited by this paper
• DNA repair synthesis in the pancreatic islets of streptozotocin-treated mice.

  1985cited by this paper
• Diabetes Induction by Subdiabetogenic Doses of Streptozotocin in BALB/cBOM Mice: Noninvolvement of Host B-Lymphocyte Functions

  1984cited by this paper
• Immunologic Studies on the Induction of Diabetes in Experimental Animals: Cellular Basis for the Induction of Diabetes by Streptozotocin

  1984cited by this paper
• Suppressive Effect of Antibodies to Immune Response Gene Products on the Development of Low-Dose Streptozotocin-induced Diabetes

  1983cited by this paper
• The effect of irradiation on the development of low-dose streptozotocin diabetes in mice.

  1983cited by this paper
• Irradiation protects against pancreatic islet degeneration and hyperglycaemia following streptozotocin treatment of mice

  1983cited by this paper
• Streptozotocin, but not alloxan, induces DNA repair synthesis in mouse pancreatic islets in vitro

  1983cited by this paper
• Survival of Intrasplenically Implanted Islets in Mice with Experimental Insulitis and Hyperglycemia

  1982cited by this paper
• A method for the purification of single A, B and D cells and for the isolation of coupled cells from isolated rat islets

  1981cited by this paper
• Insulin-dependent diabetes mellitus induced by subdiabetogenic doses of streptozotocin: obligatory role of cell-mediated autoimmune processes.

  1980cited by this paper
• Use of Reflected Green Light for Specific Identification of Islets in Vitro After Collagenase Isolation

  1979cited by this paper
• Genetic Influence of the Streptozotocin-induced Insulitis and Hyperglycemia

  1977cited by this paper
• Streptozotocin-induced pancreatic insulitis: new model of diabetes mellitus.

  1976cited by this paper
• Long-term Perfusion of Isolated Rats Islets in Vitro

  1976cited by this paper
• Immunoassayable insulin content of subcellular fractions of rat islets.

  1969cited by this paper
• Method for the Isolation of Intact Islets of Langerhans from the Rat Pancreas

  1967cited by this paper
• Immunoassay of Insulin: Two Antibody System: Plasma Insulin Levels of Normal, Subdiabetic and Diabetic Rats

  1963cited by this paper

• Comparative analysis of dose-response variability and severity in STZ-induced diabetes: female vs. male NSG mice.

  2026cites this paper
• The role of oxidative post-translational modifications in type 1 diabetes pathogenesis

  2025cites this paper
• Lowering an ER stress-regulated long noncoding RNA protects mice from diabetes and isolated pancreatic islets from cell death

  2024cites this paper
• Appropriate glycemic management protects the germline but not the uterine environment in hyperglycemia

  2024cites this paper
• Manifestation of Pathology in Animal Models of Diabetic Retinopathy Is Delayed from the Onset of Diabetes

  2024cites this paper
• A capsule-based scaffold incorporating decellularized extracellular matrix and curcumin for islet beta cell therapy in type 1 diabetes mellitus

  2024cites this paper
• Improving stroke outcomes in hyperglycemic mice by modulating tPA/NMDAR signaling to reduce inflammation and hemorrhages

  2024cites this paper
• Real‐time OXPHOS capacity analysis in wounded skin from diabetic mice: A pilot study

  2023cites this paper
• Preclinical models for Type 1 Diabetes Mellitus - A practical approach for research

  2023cites this paper
• Autoantibody and T cell responses to oxidative post-translationally modified insulin neoantigenic peptides in type 1 diabetes

  2022cites this paper
• Pathogenic Mechanism of Autoimmune Diabetes Mellitus in Humans: Potential Role of Streptozotocin-Induced Selective Autoimmunity against Human Islet β-Cells

  2022cites this paper
• Evaluation of hypoglycemic effect of (+)-1,1’-Bislunatin in streptozotocin-induced DDY male mice (Mus musculus)

  2022cites this paper
• Streptozotocin-Induced Diabetes in a Mouse Model (BALB/c) Is Not an Effective Model for Research on Transplantation Procedures in the Treatment of Type 1 Diabetes

  2021cites this paper
• The use of mice in diabetes research: The impact of physiological characteristics, choice of model and husbandry practices

  2021cites this paper
• Streptozotocin‐Induced Diabetic Models in Mice and Rats

  2021cites this paper
• Poorly controlled diabetes mellitus alters placental structure, efficiency, and plasticity

  2020cites this paper
• CCL2/MCP‐1 and CXCL12/SDF‐1 blockade by L‐aptamers improve pancreatic islet engraftment and survival in mouse

  2019cites this paper
• THE EFFECT OF SITAGLIPTIN AND MIRABEGRON ON SERUM LEPTIN, ADIPONECTIN, TUMOR NECROSIS FACTOR-α AND OXIDATIVE STRESS IN STREPTOZOTOCIN-INDUCED DIABETIC RATS

  2019cites this paper
• to on: Lin et al. (2010) Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin. Diabetes;59:2247–2252

  2018cites this paper
• A comparison of metabolomic changes in type-1 diabetic C57BL/6N mice originating from different sources

  2018cites this paper
• Streptozotocin‐Induced Diabetic Models in Mice and Rats

  2015cites this paper
• Methanolic extract of Origanum vulgare ameliorates type 1 diabetes through antioxidant, anti-inflammatory and anti-apoptotic activity.

  2015cites this paper
• Animal models of erectile dysfunction.

  2015cites this paper
• Effects of Cissampelos sympodialis Extract in a Murine Model of Streptozotocin-Induced Diabetes

  2014cites this paper
• Compound A, a selective glucocorticoid receptor agonist, inhibits immunoinflammatory diabetes, induced by multiple low doses of streptozotocin in mice

  2014cites this paper
• Autoimmune Diseases and Therapeutic Approaches

  2014cites this paper
• Do post-translational beta cell protein modifications trigger type 1 diabetes?

  2013cites this paper
• Tetracycline effects on diabetic bone regeneration

  2012cites this paper
• Single dose streptozotocin-induced diabetes: considerations for study design in islet transplantation models

  2011cites this paper
• Immune Cell–Derived C3 Is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin

  2010cites this paper
• Toxicity to the Insulin-Secreting β-Cell

  2010cites this paper
• Immune Cell Derived C3 is Required for Autoimmune Diabetes Induced by Multiple Low Doses of Streptozotocin Running title: Complement and Autoimmune Diabetes

  2010cites this paper
• Streptozotocin‐Induced Diabetic Models in Mice and Rats

  2008cites this paper
• Mechanisms and Outcomes of Drug- and Toxicant-Induced Liver Toxicity in Diabetes

  2007cites this paper
• Homing of human autoreactive T cells into pancreatic tissue of NOD-scid mice

  2004cites this paper
• Toxic Type 1 Diabetes

  2003cites this paper
• Immunization with streptozotocin-treated NOD mouse islets inhibits the onset of autoimmune diabetes in NOD mice.

  2003cites this paper
• A Dietary Cause of Type 1 Diabetes: Unearthing a New Twist to the Tale

  2002cites this paper
• A study of the factors influencing the collagenase digestion phase of human and porcine islet isolation

  2001cites this paper
• Multidose streptozotocin induction of diabetes in BALB/cBy mice induces a T cell proliferation defect in thymocytes which is reversible by interleukin-4.

  1999cites this paper
• Effects of high or low dose of streptozocin on pancreatic islets in C57BL/6 and C.B17-SCID mice.

  1998cites this paper
• Expression and immune response to islet antigens following treatment with low doses of streptozotocin in H-2d mice.

  1997cites this paper
• CD28/B7 regulation of autoimmune diabetes

  1997cites this paper
• Immunophenotyping of insulitis in control and essential fatty acid deficient mice treated with multiple low-dose streptozotocin

  1997cites this paper
• Protective Effect of Gamma-Hydroxybutyrate and Nicotinamide on Low-Dose Streptozotocin-Induced Diabetes in Mice

  1995cites this paper
• Intrathymic Transplantation of Islet Antigen Affects CD8+ Diabetogenic T-Cells Resulting in Tolerance to Autoimmune IDDM

  1995cites this paper
• Relationship between beta cell injury and antigen presentation in NOD mice.

  1995cites this paper
• Very-Low-Dose Streptozotocin Induces Diabetes in Insulin Promoter-mB7-1 Transgenic Mice

  1995cites this paper
• Essential fatty acid deficiency prevents multiple low-dose streptozotocin-induced diabetes in naive and cyclosporin-treated low-responder murine strains

  1995cites this paper
• Insulin-dependent diabetes mellitus as an autoimmune disease.

  1994cites this paper
• Multiple Low-Dose Streptozocin–induced Diabetes in NOD-scid/scid Mice in the Absence of Functional Lymphocytes

  1994cites this paper
• Autoimmune Diabetes Induced by the β-cell Toxin STZ: Immunity to the 60-kDa Heat Shock Protein and to Insulin

  1994cites this paper
• Prevention of High- and Low-Dose STZ-Induced Diabetes With D-Glucose and 5-Thio-D-Glucose

  1993cites this paper
• Resistance of the Human Fetal P‐Cell to the Toxic Effect of Multiple Low‐Dose Streptozotocin

  1993cites this paper
• Induction of tolerance to autoimmune diabetes with islet antigens

  1992cites this paper
• Alterations of islet microvasculature in mice treated with low-dose streptozocin

  1992cites this paper
• Oral prevention of type I diabetes.

  1991cites this paper
• The anti-diabetogenic effect of essential fatty acid deficiency in multiple low-dose streptozotocin-treated mice persists if essential fatty acid repletion occurs outside of a brief window of susceptibility

  1991cites this paper